Inspire starts diquafosol dry eye Phase III

ISPH started a double-blind, placebo-controlled U.S. Phase III trial of diquafosol tetrasodium 2% ophthalmic solution in about 500 patients with dry eye. In January, FDA noted that an additional trial...